Answers are grounded in this paper and cite their sources.
In this 24-week trial, mycophenolate mofetil was more effective than intravenous cyclophosphamide in inducing remission of lupus nephritis and had a more favorable safety profile.
No takes yet. Share an insight, caveat, or question.
Ginzler et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: